Feature | SCAI | May 14, 2018

SCAI 2018 Late-breaking Clinical Trials

Richard Schatz, M.D., (center) is research director of cardiovascular interventions at the Heart, Lung, and Vascular Center at Scripps Clinic, speaking at a SCAI session on collaboration with industry to bring new device technologies to market. He is best known as the co-inventor of the first coronary stent, the Palmaz-Schatz stent. Left is Ziyad Hijazi, M.D., MPH, director of the Sidra Cardiac Program. #SCAI, #SCAI2018

Richard Schatz, M.D., (center) research director of cardiovascular interventions at the Heart, Lung, and Vascular Center at Scripps Clinic, speaking at a 2018 SCAI session on collaboration with industry to bring new device technologies to market. He is best known as the co-inventor of the first coronary stent, the Palmaz-Schatz stent. Left is Ziyad Hijazi, M.D., MPH, director of the Sidra Cardiac Program, Sidra Medical and Research Center, Doha, Qatar, who has been active in new device technologies for structural heart disease.


Here is an aggregation of all the news and late-breaking studies presented at the 2018 Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions. 

 

Late-breaking Studies:

Derivation of a Simple Risk Tool to Predict 30-day Readmissions after Transcatheter Aortic Valve Replacement — Presented by Sahil Khera, M.D., Massachusetts General Hospital

Procedural, Clinical and Health Status Outcomes in Chronic Total Coronary Occlusion Revascularization with Zotarolimus-Eluting Stents: Results from the PERSPECTIVE Trial — Presented by David Kandzari, M.D., Piedmont Heart Institute

Length of Stay Post Trans-Femoral Transcatheter Aortic Valve Replacement — Presented by Siddharth Wayangankar, M.D., Shands/University of Florida

A Prospective, Single-Arm Multicenter Trial of Catheter-Directed Mechanical Thrombectomy for Intermediate-Risk Acute Pulmonary Embolism: The FLARE Study — Presented by Thomas Tu, M.D., Baptist Health Louisville

Immunomodulatory Therapy Reduces Atherosclerotic Plaque Burden by Coronary Computed Tomography Angiography in Psoriasis at One-Year — Presented by Nehal Mehta, M.D., National Heart, Lung, and Blood Institute

Culprit Vessel vs. Multivessel Revascularization Strategies in Acute Myocardial Infarction and Cardiogenic Shock: Insights from the British Columbia Cardiac Registry — Presented by Bilal Iqbal, M.D., Victoria Heart Institute Foundation, Canada

PROGRESS-CTO: The Hybrid Approach of Percutaneous Coronary Interventions for Chronic Total Occlusions — Presented by Peter Tajti, M.D., Abbott Northwestern Hospital

• The Abbott Post-Approval Study 1 MitraClip Registry: 1-year Results of the First 2,000 Patients in the Transcatheter Valve Therapy Registry — Presented by James Hermiller, M.D., The St. Vincent Medical Group at The Heart Center

Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes After Percutaneous Coronary Intervention (PCI): A PRESERVE Trial Subgroup Analysis of the Prevention of Serious Adverse Events — Presented by Santiago Garcia, M.D., Minneapolis VA Medical Center

Discrepancy Between Physician Perception and Objective Assessment of Stroke, Stent Thrombosis and Bleeding Risk in Patients with Atrial Fibrillation Undergoing PCI: Results From the Aviator 2 International Registry — Presented by Roxana Mehran, M.D., Icahn School of Medicine at Mount Sinai

 

Other Key Presentations at SCAI:

More Patients Admitted With Cardiac Conditions in Winter Than Other Months

Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs

3-D Printed Models to Guide TAVR Improve Outcomes

SCAI Launches Diagnosis and Treatment Toolkit for Peripheral Artery Disease

Medtronic Shares Two-Year Harmony Transcatheter Pulmonary Valve Results

SCAI Updates Consensus on Length of Stay for Percutaneous Coronary Intervention

SCAI Releases Consensus Guidelines for Femoral-Popliteal Arterial Interventional Device Selection

Follow other SCAI news

 

 

Other Late-breaking Cardiology Trials in 2018:

ACC 2018 Late-Breaking Trials

TCT 2018 Late-breaking Cardiovascular Clinical Trials

EuroPCR 2018 Late-breaking Trials in Interventional Cardiology

Heart Rhythm 2018 Late-breaking Studies

 

 

#SCAI2018  #SCAI18  #SCAI


Related Content

News | Cardiovascular Clinical Studies

February 21, 2024 — An 80-year-old woman from Frankenmuth, Michigan is the first Henry Ford Health structural heart ...

Home February 21, 2024
Home
News | Cardiovascular Clinical Studies

February 15, 2024 — Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and ...

Home February 15, 2024
Home
News | Cardiovascular Clinical Studies

January 3, 2024 — Cardionomic, Inc., a Minneapolis medical device company, is pleased to announce the completion of ...

Home January 03, 2024
Home
News | Cardiovascular Clinical Studies

December 19, 2023 — Peerbridge Health has announce the successful completion and findings of its prospective ...

Home December 19, 2023
Home
News | Cardiovascular Clinical Studies

December 14, 2023 — Published results of a large, national heart attack study show that patients with a life-threatening ...

Home December 14, 2023
Home
News | Cardiovascular Clinical Studies

December 11, 2023 — A world without cardiovascular disease (CVD) is possible, yet millions of lives are lost prematurely ...

Home December 11, 2023
Home
News | Cardiovascular Clinical Studies

December 8, 2023 — Procyrion, Inc., a medical device company dedicated to improving outcomes for patients with cardiac ...

Home December 08, 2023
Home
News | Cardiovascular Clinical Studies

November 29, 2023 — Inari Medical, Inc., a medical device company with a mission to treat and transform the lives of ...

Home November 29, 2023
Home
Subscribe Now